69
Participants
Start Date
August 31, 2016
Primary Completion Date
August 31, 2020
Study Completion Date
August 31, 2020
Propranolol
Propanolol will be given on a titration schedule in which participants will begin with small doses (single capsules) of the drug and increase to a larger dosage (divided over 3 capsules) over the course of three weeks. Participants aged 15-24 years will undergo an MRI.
Placebo
Placebo will be given in the form preferred by the participant and on the same schedule as the propanolol regime. Participants aged 15-24 years will undergo an MRI.
Magnetic Resonance Imaging (MRI)
An MRI will be performed on participants aged 15-24 years.
Thompson Center for Autism & Neurodevelopmental Disorders, Columbia
United States Department of Defense
FED
University of Missouri-Columbia
OTHER